In obese non-diabetic individuals, GDF-15 could predict future insulin resistance and impaired glucose control[24], and in patients free of clinically-overt cardiovascular disease, GDF-15 was positively associated with age, diabetes, hypertension, worse kidney function[22] and NT-proBNP levels[23]. This evidence concerns the gene NPPB and hypertensive disorder.